AWE
BMRA icon

Avidian Wealth Enterprises’s Biomerica BMRA Stock Holding History

Avidian Wealth Enterprises’s Portfolio BMRA Stock Details BMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,250
Closed -$55K – 396
2021
Q1 		$55K Buy
+1,250
New +$64.1K ﹤0.01% 364

Other funds holding BMRA

GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FC
Fore Capital New York $162M AUM 14.69% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HIMC
Heritage Investors Management Corp Bethesda, Maryland $3.29B AUM 26.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Avidian Wealth Enterprises's BMRA Position: Q2 2021 in Review

Avidian Wealth Enterprises sold out of Biomerica (BMRA) in Q2 2021, closing a stake of 1,250 shares — an estimated $55K sold.

Avidian Wealth Enterprises first reported a position in BMRA in Q1 2021 and held it in 1 quarter. The position peaked at $55K in Q1 2021. 26 funds tracked by Wall St. Rank hold BMRA as of Q2 2021.

  • Avidian Wealth Enterprises reported no remaining Biomerica position as of Q2 2021 after selling out during the quarter.
  • Avidian Wealth Enterprises sold 1,250 Biomerica shares in Q2 2021, an estimated $55K.
  • Avidian Wealth Enterprises first reported a position in Biomerica in Q1 2021 and held it in 1 quarter.
  • Avidian Wealth Enterprises's Biomerica position peaked at $55K in Q1 2021.
  • 26 funds tracked by Wall St. Rank held Biomerica as of Q2 2021.

Based on Avidian Wealth Enterprises's 13F filing for Q2 2021, filed 9 Aug 2021.